FDA clears path for faster gene therapy trials, cutting submission burden
FDA draft guidance allows gene therapy sponsors to reuse existing scientific data in regulatory submissions, lowering cost and timeline to clinic across the entire genome-editing sector.
Anthropic raises $65B at $965B valuation, four-way co-led
Anthropic closed a $65B Series H at a $965B post-money valuation co-led by Altimeter, Dragoneer, Greenoaks, and Sequoia, with $15B from hyperscalers including a $5B Amazon check and direct memory-supplier participation from Micron, Samsung, and SK hynix.
Mind Robotics hits $3.4B valuation on $1B+ in funding
Mind Robotics, RJ Scaringe's robotics spinout from Rivian, raised $400M at $3.4B valuation, over $1B total in six months, signaling the shift from R&D to factory-floor deployment with a real data advantage.